- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Sep 8, 1998
Clinical News
PMPA: GILD began enrollment of up to 175 HIV-positive patients in a double-blind, placebo-controlled, dose-ranging Phase II trial.
BioCentury | Apr 14, 1997
Clinical News
PMPA nucleotide analog that inhibits reverse transcriptase data
BioCentury | Oct 21, 1996
Clinical News
PMPA nucleotide inhibitor of reverse transcriptase: Phase I/II testing
Items per page:
1 - 10 of 13